Sarah Mazzilli, PhD
Assistant Professor
Boston University Chobanian & Avedisian School of Medicine
Medicine
Computational Biomedicine

PhD, University at Buffalo
MS, University at Buffalo
BS, Bridgewater State University

Pronouns: she/her/hers



Investigating the molecular events associated with the progression of premalignant squamous lung lesions for targeted chemoprevention.

Lung cancer kills more individuals in the United States annually than breast, colon and prostate cancers combined. Reduction of lung cancer mortality may be achieved by identification of those at the high risk of developing cancer, in addition to finding effective agents in which to intervene in the process. There has been limited success of candidate chemopreventive agents in lung cancer as most have selected based on work in pre-clinical models that do not adequately represent the precancerous and early stage lesions that are the focus in clinical chemoprevention trials for lung cancer. The interests of our laboratory involve developing models to aid in the understanding of the epithelial and immune modulations that are involved in the progression and regression of premalignant squamous lesions to frank lung squamous cell carcinoma with a particular focus on identifying and testing targeted agents on appropriate models that allow for translation to clinical intervention studies. To do this the our lab utilized novel single cell and multiplex imaging technologies to characterize the immune and epithelial alterations enabling lung carcinogenesis and study mechanisms to intercept this process. Our lab also works closely with members of the section of Computational Biomedicine as well as national and international collaborators on the Pre-Cancer Genome Atlas (PCGA) and the NCI- Human Tumor Atlas leading the effort to further understand the molecular underpinnings of lung cancer development to advance early detection and intervention.

Diversity, Equity, Inclusion and Accessibility

Our research group has a focus in developing a program to support trainees from diverse and underrepresented groups and fostering career development experiences in preparation for an independent career in biomedical research. We welcome all trainees including individuals who are 1st generation college students/LGBTQ+/disabled/or races/ethnicity underrepresented in STEM.

Member
Boston University
Genome Science Institute


Member
Boston University
BU-BMC Cancer Center


Member
Boston University
Evans Center for Interdisciplinary Biomedical Research




Lung Pre-Cancer Atlas (PCA) Cohort Registry
01/01/2019 - 12/31/2025 (Multi-PI)
PI: Sarah Mazzilli, PhD
Johnson & Johnson


Pre-Cancer Genome Atlas 2.0 (PCGA 2.0)
12/22/2017 - 12/31/2024 (PI)
Janssen Research & Development, LLC


Probing the physical and immune microenvironment in lung tumors at high spatiotemporal resolution
01/01/2023 - 12/31/2023 (Multi-PI)
PI: Sarah Mazzilli, PhD
Johnson & Johnson Enterprise Innovation, Inc.


Characterization a Mouse Model of Lung Squamous Premalignancy & Pre-Clinical Intervention Studies
12/22/2017 - 09/30/2023 (PI)
Janssen Research & Development, LLC


Developing in vitro systems of Jung squamous carcinoma for drug discovery
01/22/2018 - 12/31/2021 (PI)
Janssen Research & Development, LLC




Title


Yr Title Project-Sub Proj Pubs

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Marconi D, Casigliani V, Mazzilli S, Tavoschi L, Lopalco P. Migration and infectious disease risk: knowledge and perception among university students in two European countries. Ann Ig. 2024 Nov 11. PMID: 39526553
     
  2. Snyder M, Wang Z, Lara B, Fimbres J, Pichardo T, Mazzilli S, Khan MM, Duggineni VK, Monti S, Sherr DH. The Aryl Hydrocarbon Receptor Controls IFN?-Induced Immune Checkpoints PD-L1 and IDO via the JAK/STAT Pathway in Lung Adenocarcinoma. bioRxiv. 2024 Aug 13.View Related Profiles. PMID: 39185148; PMCID: PMC11343147; DOI: 10.1101/2024.08.12.607602;
     
  3. Mazzilli S, Youssouf H, Durand J, Soler M, Cholin T, Herry F, Collet L, Jean M, Ransay-Colle M, Benoit-Cattin T, Rouard C, Figoni J, Noël H, Piarroux R, Lapostolle A. Outbreak of Vibrio cholerae, Mayotte, France, April to July 2024. Euro Surveill. 2024 Aug; 29(35). PMID: 39212061; PMCID: PMC11484337; DOI: 10.2807/1560-7917.ES.2024.29.35.2400518;
     
  4. Arroyo-Ataz G, Yagüe AC, Breda JC, Mazzilli SA, Jones D. Transcriptional, developmental, and functional parallels of lymphatic and venous smooth muscle. bioRxiv. 2024 Jul 22.View Related Profiles. PMID: 39091770; PMCID: PMC11291064; DOI: 10.1101/2024.07.18.604042;
     
  5. Steiner D, Sultan L, Sullivan T, Liu H, Zhang S, LeClerc A, Alekseyev YO, Liu G, Mazzilli SA, Zhang J, Rieger-Christ K, Burks EJ, Beane J, Lenburg ME. Identification of a gene expression signature of vascular invasion and recurrence in stage I lung adenocarcinoma via bulk and spatial transcriptomics. bioRxiv. 2024 Jun 10.View Related Profiles. PMID: 38915565; PMCID: PMC11195124; DOI: 10.1101/2024.06.07.597993;
     
  6. Ysasi AB, Engler AE, Bawa PS, Wang F, Conrad RD, Yeung AK, Rock JR, Beane-Ebel J, Mazzilli SA, Franklin RA, Mizgerd JP, Murphy GJ. A specialized population of monocyte-derived tracheal macrophages promote airway epithelial regeneration through a CCR2-dependent mechanism. iScience. 2024 Jul 19; 27(7):110169.View Related Profiles. PMID: 38993668; PMCID: PMC11238131; DOI: 10.1016/j.isci.2024.110169;
     
  7. Cai L, Gao Y, DeBerardinis RJ, Acquaah-Mensah G, Aidinis V, Beane JE, Biswal S, Chen T, Concepcion-Crisol CP, Grüner BM, Jia D, Jones R, Kurie JM, Lee MG, Lindahl P, Lissanu Y, Lorz Lopez MC, Martinelli R, Mazur PK, Mazzilli SA, Mii S, Moll H, Moorehead R, Morrisey EE, Ng SR, Oser MG, Pandiri AR, Powell CA, Ramadori G, Santos Lafuente M, Snyder E, Sotillo R, Su KY, Taki T, Taparra K, Xia Y, van Veen E, Winslow MM, Xiao G, Rudin CM, Oliver TG, Xie Y, Minna JD. A Lung Cancer Mouse Model Database. bioRxiv. 2024 May 14. PMID: 38464291; PMCID: PMC10925271; DOI: 10.1101/2024.02.28.582577;
     
  8. Gindra RH, Zheng Y, Green EJ, Reid ME, Mazzilli SA, Merrick DT, Burks EJ, Kolachalama VB, Beane JE. Graph Perceiver Network for Lung Tumor and Bronchial Premalignant Lesion Stratification from Histopathology. Am J Pathol. 2024 Jul; 194(7):1285-1293.View Related Profiles. PMID: 38588853; PMCID: PMC11220922; DOI: 10.1016/j.ajpath.2024.03.009;
     
  9. Butler MLMD, Pervaiz N, Ypsilantis P, Wang Y, Cammasola Breda J, Mazzilli S, Nicks R, Spurlock E, Hefti MM, Huber BR, Alvarez VE, Stein TD, Campbell JD, McKee AC, Cherry JD. Repetitive head impacts induce neuronal loss and neuroinflammation in young athletes. bioRxiv. 2024 Mar 28.View Related Profiles. PMID: 38585925; PMCID: PMC10996668; DOI: 10.1101/2024.03.26.586815;
     
  10. Yanagawa J, Tran LM, Salehi-Rad R, Lim RJ, Dumitras C, Fung E, Wallace WD, Prosper AE, Fishbein G, Shea C, Hong R, Kahangi B, Deng JJ, Gower AC, Liu B, Campbell JD, Mazzilli SA, Beane JE, Kadara H, Lenburg ME, Spira AE, Aberle DR, Krysan K, Dubinett SM. Single-Cell Characterization of Pulmonary Nodules Implicates Suppression of Immunosurveillance across Early Stages of Lung Adenocarcinoma. Cancer Res. 2023 Oct 02; 83(19):3305-3319.View Related Profiles. PMID: 37477508; PMCID: PMC10544016; DOI: 10.1158/0008-5472.CAN-23-0128;
     
Showing 10 of 28 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 28 publications over 10 distinct years, with a maximum of 9 publications in 2024

YearPublications
20141
20151
20161
20172
20193
20202
20214
20221
20234
20249

Contact for Mentoring:

75 E. Newton St Evans Building
Boston MA 02118
Google Map


Mazzilli's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
_
Co-Authors
_
Similar People
_
Same Department